Moscow, Russia

Michail Markovich Gusyatiner


Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michail Markovich Gusyatiner: Innovator in Microbial Biotechnology

Introduction

Michail Markovich Gusyatiner is a prominent inventor based in Moscow, Russia. He is known for his significant contributions to the field of microbial biotechnology, particularly in the production of essential amino acids. His innovative work has led to advancements that benefit various industries, including food and pharmaceuticals.

Latest Patents

Gusyatiner holds a patent for a novel microbial strain and a method for producing L-threonine. The patent describes a unique strain of E. coli, specifically E. coli BKIIM B-5318, which is capable of thriving on molasses, a cost-effective raw material. This strain bears the plasmid pPRT614, which contains threonine biosynthesis genes regulated by a lambda-phage PR promoter. The microorganism is prototrophic concerning isoleucine and can produce over 70 g/l of L-threonine when cultured at temperatures between 38-41 degrees Celsius for 32 hours.

Career Highlights

Gusyatiner is associated with Ajinomoto Co., Ltd., a leading company in the field of amino acid production. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in microbial research and development.

Collaborations

Throughout his career, Gusyatiner has collaborated with notable colleagues, including Vladimir Georgievich Debabov and Uri Ivanovich Kozlov. These collaborations have fostered a productive environment for innovation and research in microbial biotechnology.

Conclusion

Michail Markovich Gusyatiner's contributions to the field of microbial biotechnology, particularly through his patent for L-threonine production, highlight his role as an influential inventor. His work continues to impact various industries, showcasing the importance of innovation in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…